期刊文献+

同种异体半关节移植治疗下肢关节端骨肿瘤 被引量:3

Half-joint Allograft Transplantation for Bone Tumors in Lower Extremity Articulation
原文传递
导出
摘要 目的:探讨分析同种异体半关节移植治疗下肢关节端骨肿瘤的疗效。方法:对23例下肢累及关节端骨肿瘤,术前根据X线、CT或MRI测量肿瘤的长短和范围,选取匹配的异体半关节及固定材料,行关节端骨肿瘤切除及同种异体半关节移植修复骨缺损术,术后X线评定骨愈合,并评估其功能恢复情况。结果:手术后6~9个月在X线片显示移植骨与正常骨组织结合部间隙消失,或间隙模糊且有足够骨痂形成,可放弃支具独立行走;术后约10~12月取出内固定材料,约14月后功能活动逐渐恢复正常。结论:同种异体半关节移植治疗下肢关节端骨肿瘤切除后骨缺损是一种切实可行的有效方法。 Objective:To investigate therapeutic effectiveness of half-joint allograft transplantation for the treatment of bone tumors in lower extremity articulation.Methods:A total of 23 cases of patients with bone tumors in lower extremity articulation were analyzed in the experiment.Before operation,length and scope of tumors were measured with X-ray,CT,MRI,and the matching half-joint allograft and fixed material were selected.Then,operation were performed to repair the bone defects by removing the tumor and performing half-joint allograft transplantation.After operation,bone healing and functional recovery were assessed with X-ray checking and other ways.Results:Six to nine months after operation,X-ray film showed that bone gap disappeared or obscured with poroma between normal bone and transplanted bone,and the patients could walk without helps.About ten to twelve months after operation,fixed material were removed.About fourteen months later,activity function went better even to normal state.Conclusion:Half-joint allograft transplantation is an effective and practical way to treat bone defect resulted from bone tumors in lower extremity articulation.
出处 《现代生物医学进展》 CAS 2010年第13期2476-2478,共3页 Progress in Modern Biomedicine
关键词 半关节移植 同种异体 下肢关节端 骨肿瘤 骨缺损 Half-joint transplantation Allograft Lower extremity articulation Bone tumors Bone defect
  • 相关文献

参考文献10

二级参考文献38

  • 1刘心,邵增务.同种异体骨关节移植在四肢骨肿瘤保肢治疗中的应用[J].中国骨肿瘤骨病,2005,4(3):181-184. 被引量:2
  • 2张俊平,潘宏铭,方勇,黄丽朋,吴金民.射频治疗对荷H22肝癌小鼠脾淋巴细胞免疫功能的影响[J].癌症,2006,25(1):34-39. 被引量:14
  • 3Platt JL. New directions for organ transplantation[ J]. Nature, 1998,392:11 - 17.
  • 4Murphy B, Auehineloss H, Carpenter CB, et al. T cell recognition of xeno - MHC peptides during concordant xenograft rejection [J].Transplantation, 1996,61:1133 - 1137.
  • 5Simeonovic CJ,Townsend MJ, Morris CF, et al. Immune mecha-nisms associated with rejection of fetal murine proislet allografts and pig proislet xenografts: comparison of intragraft cytokine mRNA pro-files[ J ]. Transplantation, 1999,67 : 963 - 971.
  • 6张学义,中华外科杂志,1981年,19卷,147页
  • 7Quintana J,Beresi V, DelPozo H,et al. Intra-arterial cisplatin given prior to surgery in osteosarcoma: grade of necrosis and size of tumor as major prognostic factors. Am J Pediatric Hematol Oncol ,1991,13 :269-273.
  • 8Bacci G, Picci P, Avella M, et al. Effect of intra-arterial versus intravenous cisplatin in addition to systemic adriamycin and high-dose methotrexate on histologic tumor response of osteosarcoma of the extremities. J Chemother, 1992,4:189-195.
  • 9Benjamin RS,Chawla SP, Carrasco CH,et al. Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum. Ann Oncol, 1992, 3 (Suppl 2):S3-S6.
  • 10Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop, 1986,204:9-24.

共引文献75

同被引文献60

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部